Repros Therapeutics Inc (RPRX)

[docbanker]

IT was probably removed b/c it was OT but it is also wrong to some degree.

While correct that the secondary marketed by Lazard (which would have also served to allow company to trade on US markets) was pulled, a deal did get done in the form of a private placement which was agencied by Cannacord. Efficacy participated in that deal.

I presume by the posting that HPtaxis was trying to imply that Osmetech was blowing up or Efficacy was stuck in an investment that couldnt raise money or Efficacy didnt have enough $ to do the deal- none are true.

My sources say there were not enough #s of investors (there was enough $ to do deal) to allow the deal to qualify for US markets.